Literature DB >> 15222473

Proteolytic activity of bovine lactoferrin.

Maria Teresa Massucci1, Francesco Giansanti, Giovanna Di Nino, Manola Turacchio, Maria Federica Giardi, Dario Botti, Rodolfo Ippoliti, Beatrice De Giulio, Barbara De Giulio, Rosa Anna Siciliano, Rosa Siciliano, Giovanna Donnarumma, Piera Valenti, Alessio Bocedi, Fabio Polticelli, Paolo Ascenzi, Giovanni Antonini.   

Abstract

Bovine lactoferrin catalyzes the hydrolysis of synthetic substrates (i.e., Z-aminoacyl-7-amido-4-methylcoumarin). Values of Km and kcat for the bovine lactoferrin catalyzed hydrolysis of Z-Phe-Arg-7-amido-4-methylcoumarin are 50 microM and 0.03 s(-1), respectively, the optimum pH value is 7.5 at 25 degrees C. The bovine lactoferrin substrate specificity is similar to that of trypsin, while the hydrolysis rate is several orders of magnitude lower than that of trypsin. The bovine lactoferrin catalytic activity is irreversibly inhibited by the serine-protease inhibitors PMSF and Pefabloc. Moreover, both iron-saturation of the protein and LPS addition strongly inhibit the bovine lactoferrin activity. Interestingly, bovine lactoferrin undergoes partial auto-proteolytic cleavage at positions Arg415-Lys416 and Lys440-Lys441. pKa shift calculations indicate that several Ser residues of bovine lactoferrin display the high nucleophilicity required to potentially catalyze substrate cleavage. However, a definitive identification of the active site awaits further studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222473     DOI: 10.1023/b:biom.0000027700.90780.45

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  8 in total

1.  Porcine and Bovine Forms of Lactoferrin Inhibit Growth of Porcine Enterotoxigenic Escherichia coli and Degrade Its Virulence Factors.

Authors:  Bert Devriendt; Eric Cox; Matthias Dierick; Hans Van der Weken; Joanna Rybarczyk; Daisy Vanrompay
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

2.  Structural determinants of limited proteolysis.

Authors:  Marat D Kazanov; Yoshinobu Igarashi; Alexey M Eroshkin; Piotr Cieplak; Boris Ratnikov; Ying Zhang; Zhanwen Li; Adam Godzik; Andrei L Osterman; Jeffrey W Smith
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

3.  Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.

Authors:  Anne Harbig; Marco Mernberger; Linda Bittel; Stephan Pleschka; Klaus Schughart; Torsten Steinmetzer; Thorsten Stiewe; Andrea Nist; Eva Böttcher-Friebertshäuser
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

4.  Activity-based mass spectrometric characterization of proteases and inhibitors in human saliva.

Authors:  Xiuli Sun; Erdjan Salih; Frank G Oppenheim; Eva J Helmerhorst
Journal:  Proteomics Clin Appl       Date:  2009-07-01       Impact factor: 3.494

5.  IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin.

Authors:  Simon R Clarke; Simon J Foster
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

6.  Sequence-derived structural features driving proteolytic processing.

Authors:  Alexander A Belushkin; Dmitry V Vinogradov; Mikhail S Gelfand; Andrei L Osterman; Piotr Cieplak; Marat D Kazanov
Journal:  Proteomics       Date:  2013-12-11       Impact factor: 3.984

Review 7.  The Nutraceutical Properties of Ovotransferrin and Its Potential Utilization as a Functional Food.

Authors:  Francesco Giansanti; Loris Leboffe; Francesco Angelucci; Giovanni Antonini
Journal:  Nutrients       Date:  2015-11-04       Impact factor: 5.717

8.  Activity-based protein profiling guided identification of urine proteinase 3 activity in subclinical rejection after renal transplantation.

Authors:  Mario Navarrete; Brice Korkmaz; Carla Guarino; Adam Lesner; Ying Lao; Julie Ho; Peter Nickerson; John A Wilkins
Journal:  Clin Proteomics       Date:  2020-06-16       Impact factor: 3.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.